| Name | Title | Contact Details |
|---|
Monetization of deprioritized or dormant intellectual property (IP) is a significant problem for IP owners across every industry. At Accencio our mission is to significantly improve the ability of IP owners to monetize this dormant value. Our technology platforms and data aggregation capabilities provide a unique, powerful visualization interface to run what-if scenarios and query internal analytical outputs. This capability allows us to identify strategic licensing opportunities previously hidden in undervalued IP. Our ultimate vision is to create a paradigm shift, changing forever the way scientific industries manage and monetize IP.
Quotit is a Irvine, CA-based company in the Computers and Electronics sector.
KNOWiNK provides a proven solution rooted in knowledge gained from our extensive experience as former election officials and from working with and listening to election authorities across the country. Our approach and innovative solution delivers an incomparable and seamless voter check-in and verification process for your election authority. We are committed to growing with your jurisdiction to meet evolving needs and helping achieve your vision to modernize elections with best-in-class technology. Therefore, KNOWiNK is in a perpetual state of development to enhance the overall election experience for voters and everyone involved with running elections. Our top priority is to continue advancing the election process to make voting easier for workers and voters alike.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.